We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,416 results
  1. Screening for Antibody Deficiencies in Adults by Serum Electrophoresis and Calculated Globin

    Purpose

    This study aimed to investigate the correlation between calculated globulin (CG, total protein level minus albumin level) and the gamma...

    Cristina Frias Sartorelli de Toledo Piza, Carolina Sanchez Aranda, ... Antonio Condino-Neto in Journal of Clinical Immunology
    Article 28 July 2023
  2. Primary antibody deficiencies in Turkey: molecular and clinical aspects

    Primary antibody deficiencies (PAD) are the most common subtype of primary immunodeficiencies, characterized by increased susceptibility to...

    Sinem Firtina, Yuk Yin Ng, ... Muge Sayitoglu in Immunologic Research
    Article 07 October 2021
  3. Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data

    Immunosuppressive drugs can alleviate debilitating symptoms of autoimmune diseases, but, by the same token, excessive immune suppression can result...

    Irina Kareva, Anup Zutshi, ... Orestis Papasouliotis in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 30 July 2021
  4. Clinical Validation of a Primary Antibody Deficiency Screening Algorithm for Primary Care

    Purpose

    The diagnostic delay of primary antibody deficiencies (PADs) is associated with increased morbidity, mortality, and healthcare costs....

    Marianne A. Messelink, Paco M. J. Welsing, ... Helen L. Leavis in Journal of Clinical Immunology
    Article Open access 16 September 2023
  5. A Novel Point-of-Care Rapid Diagnostic Test for Screening Individuals for Antibody Deficiencies

    Purpose

    No rapid diagnostic test exists to screen individuals for primary antibody deficiencies (PAD) at or near the point of care. In settings at...

    Shirli Israeli, Allison Golden, ... Roger Peck in Journal of Clinical Immunology
    Article Open access 27 November 2021
  6. Primary Antibody Deficiencies

    Primary antibody deficiencies (PADs) are the most common types of inherited primary immunodeficiency diseases (PIDs) presenting at any age, with a...
    Qing Min, **n Meng, Ji-Yang Wang in B Cells in Immunity and Tolerance
    Chapter 2020
  7. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

    Immune responses to coronavirus disease 2019 (COVID-19) mRNA vaccines in primary antibody deficiencies (PADs) are largely unknown. We investigated...

    Junghee Jenny Shin, Jennefer Par-Young, ... Insoo Kang in Journal of Clinical Immunology
    Article 17 June 2022
  8. Correction to: Primary antibody deficiencies in Turkey: molecular and clinical aspects

    Sinem Firtina, Yuk Yin Ng, ... Muge Sayitoglu in Immunologic Research
    Article 19 October 2021
  9. Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency

    Patients with primary antibody deficiency are at risk for severe and in many cases for prolonged COVID-19. Convalescent plasma treatment of...

    Julia Lang-Meli, Jonas Fuchs, ... Klaus Warnatz in Journal of Clinical Immunology
    Article Open access 10 December 2021
  10. Molecular Dynamics Methods for Antibody Design

    Complex and coordinated dynamics are closely connected with protein functions, including the binding of antibodies to antigens. Knowledge of such...
    Matthew Carter Childers, Valerie Daggett in Computer-Aided Antibody Design
    Protocol 2023
  11. Predominant Antibody Deficiency and Risk of Microscopic Colitis: a Nationwide Case–Control Study in Sweden

    Purpose 

    Predominant antibody deficiency (PAD) disorders, including common variable immunodeficiency (CVID), have been linked to increased risk of...

    Daniel V. DiGiacomo, Bjorn Roelstraete, ... Jonas F. Ludvigsson in Journal of Clinical Immunology
    Article Open access 10 May 2023
  12. Current Trends in Validating Antibody Specificities for ELISpot by Western Blotting

    The enzyme-linked immunospot (ELISpot) assay is a highly useful and sensitive method to detect total immunoglobulin and antigen-specific...
    Biji T. Kurien, R. Hal Scofield in Handbook of ELISPOT
    Protocol 2024
  13. Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort

    Background

    Terminal complement pathway deficiencies often present with severe and recurrent infections. There is a lack of good-quality data on these...

    Annalie Shears, Cathal Steele, ... Peter D. Arkwright in Journal of Clinical Immunology
    Article Open access 27 January 2022
  14. Immunological and Clinical Phenoty** in Primary Antibody Deficiencies: a Growing Disease Spectrum

    Purpose

    Although common variable immunodeficiency (CVID) is considered the most prevalent symptomatic primary antibody deficiency (PAD), there is a...

    Junghee J. Shin, Daniel Liauw, ... Insoo Kang in Journal of Clinical Immunology
    Article 02 April 2020
  15. Single-domain antibody-based protein degrader for synucleinopathies

    Synucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein (α-syn) in the brain, leading to motor...

    Yixiang Jiang, Yan Lin, ... Einar M. Sigurdsson in Molecular Neurodegeneration
    Article Open access 31 May 2024
  16. T cell independent antibody responses with class switch and memory using peptides anchored on liposomes

    Vaccines generally require T lymphocytes for B-cell activation and immunoglobulin class switching in response to peptide or protein antigens. In the...

    Ásdís Hjálmsdóttir, Fabio Hasler, ... Pål Johansen in npj Vaccines
    Article Open access 22 June 2024
  17. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine

    Purpose

    CD8 cytotoxic T cells (CTLs) play a critical role in the clearance of virally infected cells. SARS-CoV-2-specific CD8 T cells and functional...

    Sudhir Gupta, Sudhanshu Agrawal, ... Yesim Demirdag in Journal of Clinical Immunology
    Article 02 April 2022
  18. Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

    Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their...

    Valeria Fumagalli, Micol Ravà, ... Matteo Iannacone in Nature Immunology
    Article Open access 14 March 2024
  19. Common Variable Immunodeficiency, Hypogammaglobulinemia, and Specific Antibody Deficiency

    Antibody deficiencies are a group of primary immune deficiencies caused by defects in B-cell development, B-cell activation, or antibody synthesis....
    Heather K. Lehman, Parteet Sandhu in Primary and Secondary Immunodeficiency
    Chapter 2021
Did you find what you were looking for? Share feedback.